Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

New AI tool aims to catch postpartum depression before it starts

NCT ID NCT06818734

Knowledge-focused Sponsor: Weill Medical College of Cornell University Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now This study
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 25, 2026 · Last updated Jul 31, 2026 · Updated 3 times

Summary

This study tests a computer tool that uses artificial intelligence to alert doctors when a pregnant patient may be at high risk for postpartum depression. The tool gives doctors a risk score and suggests steps like referrals or educational materials. Researchers will ask 160 pregnant women and their doctors whether the tool is helpful, easy to use, and practical in real clinic settings.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Clinical decision support tool (AI algorithm)
What this could lead to
If successful, this tool could help doctors spot postpartum depression risk earlier and connect mothers to support sooner.
What could go wrong
This is a small, early-stage study focused on whether doctors find the tool useful, not yet on whether it actually prevents depression. The tool only alerts doctors—it doesn't guarantee any action or better outcomes.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 160 people

The number the study aims to enrol. It can still change while the study runs.

Started

Jul 2026

Expected to finish

Dec 2026

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 years and older

Sex

Female participants only

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * 18 years or older * being seen at one of participating clinics * pregnancy at 20 week gestation or more Exclusion Criteria: * Does not speak inclusion * does not have internet access Clinician eligibility: * If they manage patients in the three clinics as a board-certified OBGYN clinician. * No exclusion criteria apply for clinician based on their knowledge and experience in treating PPD

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Postpartum depression are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

postpartum depression prevention target

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Postpartum depression

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    4 sites. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Center for Community Health: 515 6th street (3rd floor)

    NOT_YET_RECRUITING

    Brooklyn, New York, 11215, United States

  • Ob GYN Lower Manhattan 156 William street, New York City

    RECRUITING

    New York, New York, 10038, United States

  • Weill Cornell Medicine OBGYN practice 72 street

    RECRUITING

    New York, New York, 10065, United States

  • Weill Cornell Medicine- Women's Health practice 505 East 70th street, New York City

    RECRUITING

    New York, New York, 10065, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.